Abstract:This symposium aims at giving further insights in the immune response of patients with panic disorder (PD) and patients with post-traumatic stress disorder (PTSD) compared to healthy individuals. Additionally, the impact of non-pharmacological interventions on biomarkers and the influence of biomarkers on intervention outcome is presented. Implications of these findings for the development of somatic diseases, non-pharmacological intervention approaches and directions for future research are discussed. Different past studies already showed alterations of body systems in patients with mental disorders and deviations from the functioning of body systems of healthy individuals. Especially the hypothalamus-pituitary-adrenal (HPA) axis was of interest and dysfunctions of the HPA-axis of patients with mental disorders were shown. In PD and PTSD, a blunted response of the HPA-axis is a relatively consistent finding. This, in turn, seems to have an influence on the immune system because of an interaction of the HPA-axis and the immune system. The immune system could play a major role in the development of somatic diseases, which might be the missing link between HPA-axis dysfunction and elevated risks for somatic diseases and higher mortality rates of PD and PTSD patients. In past studies, a pro-inflammatory state with higher concentrations of pro-inflammatory markers such as IL-6 and TNF-α was found relatively consistent in baseline conditions in PD and PTSD. The influence of stress on biomarkers of the immune system and the role of anti-inflammatory cytokines remains rather unclear. Therefore, in this symposium, studies are presented which assessed biomarkers of the immune system in both disorders at rest or under acute stress after the Trier Social Stress Test compared to healthy controls. For both disorders, PD and PTSD, alterations of the immune system under acute stress can be shown. The results provide tentative evidence for a low-grade inflammatory process in PD and PTSD patients under acute stress, possibly representing a missing link factor between these diagnoses and the increased risk for somatic diseases. Further assumptions regarding the function of the immune system in PD and PTSD can be drawn based on the findings of the presented studies. Future studies should address underlying mechanisms of the immune response in different mental disorders and its interactions with other body systems influencing the development of somatic diseases. As dysfunctions of the immune system may result in a higher risk for somatic diseases and higher mortality rates of individuals with PD or PTSD, it is of major interest to assess interventions influencing the function of the immune system and to assess the influence of immune biomarkers on interventions. Therefore, in this symposium studies investigating the association between different interventions (slow-paced breathing with heart rate variability biofeedback, psychotherapy) and biomarkers of the immune system in PD and PTSD are presented. A slow-paced breathing with heart rate variability biofeedback intervention for PD patients showed positive effects on biomarkers of the immune system via the cholinergic anti-inflammatory pathway. Based on the assumed chronic systemic low- grade inflammation in PD, generalized proinflammatory state in PD, and association of inflammation and future cardiovascular events, slow-paced breathing with heart rate variability biofeedback is a useful non-invasive treatment to reduce the pro-inflammatory state in individuals with PD. Additionally, when assessing psychotherapy outcome, it was found that concentrations of cytokines before psychotherapy did not predict therapy outcome of PD patients but of PTSD patients. In the PTSD patient group, pro- and anti-inflammatory cytokine concentrations under acute stress before psychotherapy predicted therapy outcome. Biomarkers of the immune system therefore seem to play a major role in the maintenance of PTSD. As this was not found for PD, underlying mechanisms of the influence of the immune system on psychotherapy outcome are of major interest and their role in the maintenance of other disorders should be assessed in future studies. Further approaches for the implementation of the biofeedback training are shown and possibilities for future non-pharmacological treatments in PD and PTSD are discussed. The proposed symposium demonstrates current results regarding the function of the immune system of PD and PTSD patients under acute stress and its influence on psychotherapy outcome. Additionally, the possibility of influencing immune markers of PD patients via a slow-paced breathing with heart rate variability biofeedback is shown. This symposium gives further insights in the reactivity of the immune system in different patient groups and allows to draw conclusions regarding its role in the development of somatic diseases and maintenance of mental disorders. A first non-pharmacological intervention for influencing biomarkers of the immune system is presented and future possibilities of implementation are discussed. This symposium and the included studies can be starting points for future research addressing underlying mechanisms of the immune response in mental disorders as well as developing further non-pharmacological interventions.

Alterations in pro-inflammatory cytokine TNF-alpha and stimulation of the cholinergic anti-inflammatory pathway in individuals with panic disorder using slow-paced breathing with HRV-BF – a randomized controlled trial

Stress-induced cytokine levels in patients with panic disorder and its prediction of psychotherapy outcome

Biomarkers of the immune system in panic disorder and post-traumatic stress disorder and their association with non-pharmacological interventions

Neurophysiological Approach by Self-Control of Your Stress-Related Autonomic Nervous System with Depression, Stress and Anxiety Patients

Slow-Paced Breathing Intervention in Healthcare Workers Affected by Long COVID: Effects on Systemic and Dysfunctional Breathing Symptoms, Manual Dexterity and HRV

Effects of Aerobic Exercise on Anxiety Symptoms and Cortical Activity in Patients with Panic Disorder: A Pilot Study

Exploring the Impact of a 7-Week Heart Rate Variability Biofeedback Protocol on Skin Severity, Quality of Life, and Mental Health in a Proof-of-Concept Pre–Post Trial of Individuals with Psoriasis

Effects of Heart Rate Variability Biofeedback Training on Anxiety Reduction and Brain Activity: a Randomized Active-Controlled Study Using EEG

Compassionate mind training for people with Parkinson's disease: A pilot study and predictors of response

Blood endocannabinoid levels in patients with panic disorder

A randomized controlled trial on the effects and acceptability of individual mindfulness techniques - meditation and yoga - on anxiety and depression in people with Parkinson's disease: a study protocol

Biomarkers as predictors of CBT responsiveness in major depressive disorder: The role of heart rate variability and inflammation

Investigating effective treatment factors in brief cognitive behavioral therapy for panic disorder

Real-world outcomes of an innovative digital therapeutic for treatment of panic disorder and PTSD: A 1,500 patient effectiveness study

Effects of antidepressant on FKBP51 mRNA expression and neuroendocrine hormones in patients with panic disorder

Heart Rate Variability Biofeedback Increased Autonomic Activation and Improved Symptoms of Depression and Insomnia among Patients with Major Depression Disorder

A pilot study investigating the relationship between heart rate variability and blood pressure in young adults at risk for cardiovascular disease

A pilot study augmenting cognitive behavioral therapy for panic disorder with attention bias modification: Clinical and psychophysiological outcomes

Emotion regulation and heart rate variability may identify the optimal posttraumatic stress disorder treatment: analyses from a randomized controlled trial

Breaking the Fear Barrier: Aberrant Activity of Fear Networks as a Prognostic Biomarker in Patients with Panic Disorder Normalized by Pharmacotherapy

Implementing Mobile HRV Biofeedback as Adjunctive Therapy During Inpatient Psychiatric Rehabilitation Facilitates Recovery of Depressive Symptoms and Enhances Autonomic Functioning Short-Term: A 1-Year Pre-Post-intervention Follow-Up Pilot Study